DEVELOPMENT AND INTERNAL VALIDATION OF A NOVEL NOMOGRAM PREDICTING BLADDER CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY. RESULTS FROM A TWO INSTITUTION SERIES | Zendy

AI Assistant Blog Pricing

DEVELOPMENT AND INTERNAL VALIDATION OF A NOVEL NOMOGRAM PREDICTING BLADDER CANCER SPECIFIC SURVIVAL OF PATIENTS WITH PT0 DISEASE FOLLOWING RADICAL CYSTECTOMY. RESULTS FROM A TWO INSTITUTION SERIES

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.